SYRA Syra Health
- 1.370
- -0.010-0.72%
- 1.330
- -0.040-2.92%
Syra Health News
Syra Health | 8-K: Current report
Syra Health | 8-K: Syra Health Announces First Quarter 2024 Financial Results, Led By Strong Revenue Growth of 47%. Conference call will be held today, Thursday, May 9 at 9:00 am ET
Syra Health | 10-Q: Quarterly report
Syra Health | DEFA14A: Others
Syra Health | ARS: Annual Report to Security Holders
Syra Health | DEF 14A: Definitive information statements
Syra Health | 8-K: Current report
Syra Health | 8-K: Syra Health Announces Fourth-Quarter and Full-Year 2023 Financial Results. Projects 2024 Revenue Growth of 64% to 100%. Conference call will be held today, Monday, March 25 at 9:00am ET
Syra Health | 10-K: Annual report
Syra Health | SC 13G: Statement of acquisition of beneficial ownership by individuals-Mike Edward McAleer(000%)
Syra Health | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-SLS Group LLC(0.00%)
Syra Health | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-SLS Group LLC(7.64%)
Syra Health | 4: Statement of changes in beneficial ownership of securities-CEO Vuppalanchi Deepika
Syra Health | 4: Statement of changes in beneficial ownership of securities-10% Owner Syed Feroz
Syra Health | 4: Statement of changes in beneficial ownership of securities-Officer Allam Sandeep
Syra Health | 8-K: Syra Health Announces Third Quarter 2023 Financial Results Conference call will be held today, Tuesday, November 14 at 9:00am ET
Syra Health | 10-Q: Quarterly report
Syra Health | SC 13G: Statement of acquisition of beneficial ownership by individuals
Syra Health | 4: Statement of changes in beneficial ownership of securities-Director Paranjape Ketan
Syra Health | 4: Statement of changes in beneficial ownership of securities-Director Dahlem Andrew
Analysis
Price Target
No Data
